Table of Contents

Global Polymyositis Treatment Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Polymyositis Treatment Market Size 2014-2024
  • 2.1.2 Polymyositis Treatment Market Size CAGR by Region
• 2.2 Polymyositis Treatment Segment by Type
  • 2.2.1 Immunosuppressant
  • 2.2.2 Immunosuppressant
  • 2.2.3 Immunoglobulin
  • 2.2.4 Monoclonal Antibodies
  • 2.2.5 Corticosteroids
• 2.3 Polymyositis Treatment Market Size by Type
  • 2.3.1 Global Polymyositis Treatment Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Polymyositis Treatment Market Size Growth Rate by Type (2014-2019)
• 2.4 Polymyositis Treatment Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinic
  • 2.4.3 Others
• 2.5 Polymyositis Treatment Market Size by Application
  • 2.5.1 Global Polymyositis Treatment Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Polymyositis Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Polymyositis Treatment by Players

• 3.1 Global Polymyositis Treatment Market Size Market Share by Players
  • 3.1.1 Global Polymyositis Treatment Market Size by Players (2017-2019)
  • 3.1.2 Global Polymyositis Treatment Market Size Market Share by Players (2017-2019)
• 3.2 Global Polymyositis Treatment Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Polymyositis Treatment by Regions

• 4.1 Polymyositis Treatment Market Size by Regions
• 4.2 Americas Polymyositis Treatment Market Size Growth
• 4.3 APAC Polymyositis Treatment Market Size Growth
• 4.4 Europe Polymyositis Treatment Market Size Growth
• 4.5 Middle East & Africa Polymyositis Treatment Market Size Growth

5 Americas

• 5.1 Americas Polymyositis Treatment Market Size by Countries
• 5.2 Americas Polymyositis Treatment Market Size by Type
• 5.3 Americas Polymyositis Treatment Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Polymyositis Treatment Market Size by Countries
• 6.2 APAC Polymyositis Treatment Market Size by Type
• 6.3 APAC Polymyositis Treatment Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Polymyositis Treatment by Countries
• 7.2 Europe Polymyositis Treatment Market Size by Type
• 7.3 Europe Polymyositis Treatment Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Polymyositis Treatment by Countries
• 8.2 Middle East & Africa Polymyositis Treatment Market Size by Type
• 8.3 Middle East & Africa Polymyositis Treatment Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Polymyositis Treatment Market Forecast

• 10.1 Global Polymyositis Treatment Market Size Forecast (2019-2024)
• 10.2 Global Polymyositis Treatment Forecast by Regions
  • 10.2.1 Global Polymyositis Treatment Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Polymyositis Treatment Forecast by Type
• 10.8 Global Polymyositis Treatment Forecast by Application

11 Key Players Analysis

• 11.1 Fresenius SE & Co. KGaA
  • 11.1.1 Company Details
  • 11.1.2 Polymyositis Treatment Product Offered
  • 11.1.3 Fresenius SE & Co. KGaA Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Fresenius SE & Co. KGaA News
• 11.2 Antares Pharma, Inc.
  • 11.2.1 Company Details
  • 11.2.2 Polymyositis Treatment Product Offered
  • 11.2.3 Antares Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Antares Pharma, Inc. News
• 11.3 Hospira, Inc.
  • 11.3.1 Company Details
  • 11.3.2 Polymyositis Treatment Product Offered
  • 11.3.3 Hospira, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Hospira, Inc. News
• 11.4 Mylan N.V.
  • 11.4.1 Company Details
  • 11.4.2 Polymyositis Treatment Product Offered
  • 11.4.3 Mylan N.V. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Mylan N.V. News
• 11.5 Medexus Pharma, Inc.
  • 11.5.1 Company Details
  • 11.5.2 Polymyositis Treatment Product Offered
  • 11.5.3 Medexus Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Medexus Pharma, Inc. News
• 11.6 Novartis AG
  • 11.6.1 Company Details
  • 11.6.2 Polymyositis Treatment Product Offered
  • 11.6.3 Novartis AG Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Novartis AG News
• 11.7 Alcami Corporation
  • 11.7.1 Company Details
  • 11.7.2 Polymyositis Treatment Product Offered
  • 11.7.3 Alcami Corporation Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Alcami Corporation News
• 11.8 Genentech, Inc.
  • 11.8.1 Company Details
  • 11.8.2 Polymyositis Treatment Product Offered
  • 11.8.3 Genentech, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Genentech, Inc. News
• 11.9 Teva Pharmaceuticals
  • 11.9.1 Company Details
  • 11.9.2 Polymyositis Treatment Product Offered
  • 11.9.3 Teva Pharmaceuticals Polymyositis Treatment Revenue, Gross Margin and Market Share (2017-2019)
  • 11.9.4 Main Business Overview
  • 11.9.5 Teva Pharmaceuticals News

12 Research Findings and Conclusion

According to this study, over the next five years the Polymyositis Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Polymyositis Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Polymyositis Treatment market by product type, application, key companies and key regions.

This study considers the Polymyositis Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Immunosuppressant
Alkylating Agent
Immunoglobulin
Monoclonal Antibodies
Corticosteroids

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Fresenius SE & Co. KGaA
Antares Pharma, Inc.
Hospira, Inc.
Mylan N.V.
Medexus Pharma, Inc.
Novartis AG
Alcami Corporation
Genentech, Inc.
Teva Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Polymyositis Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Polymyositis Treatment market by identifying its various subsegments.
Focuses on the key global Polymyositis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Polymyositis Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Polymyositis Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.